key: cord-0800504-unp5bjuc
authors: Mungmunpuntipantip, Rujittika; Wiwanitkit, Viroj
title: Acute venous thromboembolism after COVID-19 vaccination
date: 2021-12-14
journal: J Vasc Surg Venous Lymphat Disord
DOI: 10.1016/j.jvsv.2021.08.024
sha: 32e43eac768194a74a7e9c2b6d4a90de5f872897
doc_id: 800504
cord_uid: unp5bjuc

nan

We would like to share ideas on "Three cases of acute venous thromboembolism in females following vaccination for COVID-19." 1 Andraska et al concluded that "We present a series of three women who developed venous thromboembolism (VTE) following mRNA-1273 vaccination at a single healthcare system." 1 Pathogenesis of acute venous thromboembolism is an interesting issue. In the present report, mRNA COVID-19 vaccine is used. The autoimmunity development after mRNA COVID-19 vaccine administration is proposed, and it might be mentioned as a cause of thrombotic disorder. 2 However, if an autoimmune problem is referred to, there should be an identification of problematic antibody. In the present case, there is also other possible pathomechanism. After vaccination, the rapid blood viscosity change can occur and this might cause rheological change. 3 The acute thromboembolism might be the result. 

We thank the authors for the response to our case series entitled "Three cases of acute venous thromboembolism in females following vaccination for COVID-19." 1 Previous reports have outlined thrombotic complications following COVID-19 vaccination and have suggested a possible mechanism involving an immune thrombotic thrombocytopenia mediated by platelet-activating antibody against PF4. 2, 3 Committing to a mechanism to explain this phenomenon is out of the scope of this case series, but we welcome other suggestions from our colleagues. It is possible that thrombotic events after vaccination could be due to the changes in blood viscosity and rheological change, as suggested by Mungmunpuntipantip and Wiwanitkit.

Three cases of acute venous thromboembolism in females following vaccination for COVID-19

Do COVID-19 RNA-based vaccines put at risk of immunemediated diseases? In reply to "potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases

Blood viscosity of COVID-19 patient: a preliminary report

Three cases of acute venous thromboembolism in females following vaccination for COVID-19

Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination

Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination